Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 405

Similar articles for PubMed (Select 12766111)

1.

The health care costs of diabetic peripheral neuropathy in the US.

Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA.

Diabetes Care. 2003 Jun;26(6):1790-5.

PMID:
12766111
2.

The health care costs of diabetic nephropathy in the United States and the United Kingdom.

Gordois A, Scuffham P, Shearer A, Oglesby A.

J Diabetes Complications. 2004 Jan-Feb;18(1):18-26.

PMID:
15019595
3.

Economic costs of diabetes in the US in 2002.

Hogan P, Dall T, Nikolov P; American Diabetes Association.

Diabetes Care. 2003 Mar;26(3):917-32.

PMID:
12610059
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
5.

Economic costs of diabetes in the U.S. In 2007.

American Diabetes Association.

Diabetes Care. 2008 Mar;31(3):596-615. doi: 10.2337/dc08-9017. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271.

PMID:
18308683
6.

Predicted costs and outcomes from reduced vibration detection in people with diabetes in the U.S.

Shearer A, Scuffham P, Gordois A, Oglesby A.

Diabetes Care. 2003 Aug;26(8):2305-10.

PMID:
12882853
7.
9.
10.

Predictors, consequences and costs of diabetes-related lower extremity amputation complicating type 2 diabetes: the Fremantle Diabetes Study.

Davis WA, Norman PE, Bruce DG, Davis TM.

Diabetologia. 2006 Nov;49(11):2634-41. Epub 2006 Sep 26.

PMID:
17001469
11.

Direct medical costs of complications resulting from type 2 diabetes in the U.S.

O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ.

Diabetes Care. 1998 Jul;21(7):1122-8.

PMID:
9653606
12.
13.

The impact of diabetes on workforce participation: results from a national household sample.

Vijan S, Hayward RA, Langa KM.

Health Serv Res. 2004 Dec;39(6 Pt 1):1653-69.

14.

Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis.

Sullivan PW, Follin SL, Nichol MB.

Pharmacoeconomics. 2004;22(14):929-42.

PMID:
15362929
15.

[Direct and indirect diabetes costs in the world].

Logminiene Z, Norkus A, Valius L.

Medicina (Kaunas). 2004;40(1):16-26. Review. Lithuanian.

16.

The direct medical cost of type 2 diabetes.

Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, Brown MB, Herman WH.

Diabetes Care. 2003 Aug;26(8):2300-4.

PMID:
12882852
17.
18.

The cost of diabetes in Latin America and the Caribbean.

Barceló A, Aedo C, Rajpathak S, Robles S.

Bull World Health Organ. 2003;81(1):19-27. Epub 2003 Mar 11.

19.

Lowering the risk of neuropathy, foot ulcers and amputations.

Boulton AJ.

Diabet Med. 1998;15 Suppl 4:S57-9. Review.

PMID:
9868994
20.

The medical cost of cardiometabolic risk factor clusters in the United States.

Sullivan PW, Ghushchyan V, Wyatt HR, Hill JO.

Obesity (Silver Spring). 2007 Dec;15(12):3150-8. doi: 10.1038/oby.2007.375.

PMID:
18198326
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk